Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA/NIH GENE THERAPY DATABASE FUTURE FUNDING IN QUESTION, CBER's NOGUCHI CAUTIONS RAC IN MEMO; CANCER GENE THERAPY, RARE DISEASE AND AIDS PROTOCOLS OKed

Executive Summary

Future funding for the collaborative gene therapy database being created by FDA and the National Institutes of Health may be in jeopardy, FDA Division of Cellular and Gene Therapies Director Philip Noguchi, MD, warned in a memorandum presented to the National Institutes of Health Recombinant DNA Advisory Committee at its June 8-9 meeting in Bethesda, Md.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026369

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel